Sunshine Biopharma Files 2025 Annual Report
Ticker: SBFM · Form: 10-K · Filed: 2026-04-03T11:58:23-04:00
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Sunshine Biopharma dropped its 2025 10-K. All the deets are in there.
AI Summary
Sunshine Biopharma Inc. filed its annual report on Form 10-K for the period ending December 31, 2025. The filing, accepted on April 3, 2026, includes detailed financial information and disclosures. The company is involved in the pharmaceutical preparations industry, specifically within the life sciences sector.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Sunshine Biopharma's financial health and operational status for the fiscal year 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Sunshine Biopharma is subject to significant regulatory, research, and market risks inherent in the industry.
Key Numbers
- 0001402328 — CIK (Unique identifier for Sunshine Biopharma Inc. on EDGAR)
- 205566275 — EIN (Employer Identification Number for Sunshine Biopharma Inc.)
- 2834 — SIC Code (Standard Industrial Classification code for Pharmaceutical Preparations)
Key Players & Entities
- Sunshine Biopharma Inc. (company) — Filer of the 10-K report
- December 31, 2025 (date) — Period of report for the 10-K
- April 3, 2026 (date) — Filing date and acceptance date of the 10-K
- BUSH & ASSOCIATES CPA LLC (company) — Consent of Accountant
- M&K CPAS, PLLC (company) — Consent of Accountant
FAQ
What is the primary business of Sunshine Biopharma Inc.?
Sunshine Biopharma Inc. is primarily involved in Pharmaceutical Preparations, classified under SIC code 2834 and within the Life Sciences sector.
When was the 2025 annual report filed and accepted?
The 2025 annual report (Form 10-K) was filed and accepted on April 3, 2026.
What is the fiscal year end for Sunshine Biopharma Inc.?
The fiscal year end for Sunshine Biopharma Inc. is December 31.
What are the mailing and business addresses listed for Sunshine Biopharma Inc.?
The mailing and business addresses for Sunshine Biopharma Inc. are both listed as 333 LAS OLAS WAY CU4 SUITE 433, FORT LAUDERDALE FL 33301.
Which accounting firms provided consent for this filing?
BUSH & ASSOCIATES CPA LLC and M&K CPAS, PLLC provided consent for this filing.
From the Filing
EDGAR Filing Documents for 0001683168-26-002644 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001683168-26-002644 Filing Date 2026-04-03 Accepted 2026-04-03 11:58:23 Documents 86 Period of Report 2025-12-31 Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 10-K FOR DEC 2025 sunshine_i10k-123125.htm iXBRL 10-K 1079582 2 CONSENT OF BUSH & ASSOCIATES CPA LLC sunshine_ex2301.htm EX-23.1 4295 3 CONSENT OF M&K CPAS, PLLC sunshine_ex2302.htm EX-23.2 3862 4 CERTIFICATION sunshine_ex3101.htm EX-31.1 10483 5 CERTIFICATION sunshine_ex3102.htm EX-31.2 10480 6 CERTIFICATION sunshine_ex3201.htm EX-32.1 5129 12 GRAPHIC image_001.jpg GRAPHIC 6215 13 GRAPHIC image_003.jpg GRAPHIC 14603 14 GRAPHIC bushheader.jpg GRAPHIC 11570 15 GRAPHIC image_002.jpg GRAPHIC 7467 Complete submission text file 0001683168-26-002644.txt 5623932 Data Files Seq Description Document Type Size 7 XBRL SCHEMA FILE sbfm-20251231.xsd EX-101.SCH 43956 8 XBRL CALCULATION FILE sbfm-20251231_cal.xml EX-101.CAL 66533 9 XBRL DEFINITION FILE sbfm-20251231_def.xml EX-101.DEF 138037 10 XBRL LABEL FILE sbfm-20251231_lab.xml EX-101.LAB 363655 11 XBRL PRESENTATION FILE sbfm-20251231_pre.xml EX-101.PRE 303584 90 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123125_htm.xml XML 723347 Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684 Sunshine Biopharma Inc. (Filer) CIK : 0001402328 (see all company filings) EIN. : 205566275 | State of Incorp.: CO | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)